Literature DB >> 11437440

Evidence that protein kinase C (PKC) participates in the meiosis I to meiosis II transition in mouse oocytes.

M M Viveiros1, Y Hirao, J J Eppig.   

Abstract

Oocytes from LTXBO mice exhibit a delayed entry into anaphase I and frequently enter interphase after the first meiotic division. This unique oocyte model was used to test the hypothesis that protein kinase C (PKC) may regulate the meiosis I-to-meiosis II transition. PKC activity was detected in LTXBO oocytes at prophase I and increased with meiotic maturation, with the highest (P < 0.05) activity observed at late metaphase I (MI). Treatment of late MI-stage oocytes with the PKC inhibitor, bisindolylmaleimide I (BIM), transiently reduced (P < 0.05) M-phase-promoting factor (MPF) activity and promoted (P < 0.05) progression to metaphase II (MII), while mitogen-activated protein kinase (MAPK) activity remained elevated during the MI-to-MII transition. Confocal microscopy analysis of LTXBO oocytes during this transition showed PKC-delta associated with the meiotic spindle and then with the chromosomes at MII. Inhibition of PKC activity also prevented untimely entry into interphase, but only when PKC activity was reduced in oocytes before the progression to MII and thus indicates that the transition into interphase is directly associated with the delayed triggering of anaphase I. Moreover, the defect(s) that initiate activation occur upstream of MAPK, as suppression of PKC activity failed to prevent activation by Mos(tm1Ev)/ Mos(tm1Ev) LTXBO oocytes expressing no detectable MAPK activity. In summary, PKC participates in the regulatory mechanisms that delay entry into anaphase I in LTXBO oocytes, and the disruption promotes untimely entry into interphase. Thus, loss of regulatory control over PKC activity during oocyte maturation disrupts the critical MI-to-MII transition, leading to a precocious exit from meiosis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437440     DOI: 10.1006/dbio.2001.0311

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  8 in total

Review 1.  Ca2+ signaling during mammalian fertilization: requirements, players, and adaptations.

Authors:  Takuya Wakai; Veerle Vanderheyden; Rafael A Fissore
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

2.  PKCβ1 regulates meiotic cell cycle in mouse oocyte.

Authors:  Zi-Yun Yi; Qiu-Xia Liang; Tie-Gang Meng; Jian Li; Ming-Zhe Dong; Yi Hou; Ying-Chun Ouyang; Chun-Hui Zhang; Heide Schatten; Qing-Yuan Sun; Jie Qiao; Wei-Ping Qian
Journal:  Cell Cycle       Date:  2019-02-07       Impact factor: 4.534

3.  Involvement of PKCζ and GSK3β in the stability of the metaphase spindle.

Authors:  Madhavi Kalive; D Page Baluch; David G Capco
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-12-17       Impact factor: 2.416

Review 4.  The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development.

Authors:  Tom Ducibella; Rafael Fissore
Journal:  Dev Biol       Date:  2008-02-05       Impact factor: 3.582

5.  Perturbing microtubule integrity blocks AMP-activated protein kinase-induced meiotic resumption in cultured mouse oocytes.

Authors:  Ru Ya; Stephen M Downs
Journal:  Zygote       Date:  2012-11-16       Impact factor: 1.442

6.  PKCδ promotes fertilization of mouse embryos in early development via the Cdc25B signaling pathway.

Authors:  Yanchun Liu; Xin Deng; Didi Wu; Minglin Jin; Bingzhi Yu
Journal:  Exp Ther Med       Date:  2019-08-29       Impact factor: 2.447

7.  The dynamics of PKC-induced phosphorylation triggered by Ca2+ oscillations in mouse eggs.

Authors:  Jose Raul Gonzalez-Garcia; Zoltan Machaty; F Anthony Lai; Karl Swann
Journal:  J Cell Physiol       Date:  2013-01       Impact factor: 6.384

8.  Zinc regulates meiotic resumption in porcine oocytes via a protein kinase C-related pathway.

Authors:  Ming-Hui Zhao; Jung-Woo Kwon; Shuang Liang; Seon-Hyang Kim; Ying-Hua Li; Jeong-Su Oh; Nam-Hyung Kim; Xiang-Shun Cui
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.